Diagnostic Challenges Due to Phenocopies: Lessons from Multiple Endocrine Neoplasia Type1 (MEN1)

被引:59
作者
Turner, Jeremy J. O. [1 ,2 ]
Christie, Paul T. [1 ]
Pearce, Simon H. S. [3 ]
Turnpenny, Peter D. [4 ]
Thakker, Rajesh V. [1 ]
机构
[1] Univ Oxford, OCDEM, Churchill Hosp, Nuffield Dept Clin Med,Acad Endocrine Unit, Oxford OX3 7LJ, England
[2] Norfolk & Norwich Univ Hosp, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England
[3] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[4] Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX1 2ED, Devon, England
基金
英国医学研究理事会;
关键词
Hyperparathyroidism-jaw-tumour syndrome; HPT-JT; familial hypocalciuric hypercalcaemia; FHH; calciumsensing receptor; CaSR; parafibromin; hyperparathyroidism type 2; HRPT2; parathyroid; pancreas; JAW TUMOR SYNDROME; MUTATIONS; GENE; HYPERPARATHYROIDISM; IDENTIFICATION; CHROMOSOME-11; ASSOCIATION; ALLELES;
D O I
10.1002/humu.21170
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Phenocopies may confound the clinical diagnoses of hereditary disorders. We report phenocopies in Multiple Endocrine Neoplasia type 1 (MEN1), an autosomal dominant disorder, characterised by the combined occurrence of parathyroid, pituitary and pancreatic tumours. We studied 261 affected individuals from 74 families referred with a clinical diagnosis of MEN1 and sought inconsistencies between the mutational and clinical data. We identified four patients from unrelated families with phenocopies. Patients 1 and 2 from families with MEN1, developed prolactinomas as the sole endocrinopathy but they did not harbour the germline MEN1 mutation present in their affected relatives. Patient 3, had acromegaly and recurrent hypercalcaemia following parathyroidectomy, whilst patient 4 had parathyroid tumours and a microprolactinoma. Patients 3 and 4 and their relatives did not have MEN1 mutations, but instead had familial hypocalciuric hypercalcaemia (FHH) due to a calcium-sensing receptor mutation (p.Arg680Cys), and the hyperparathyroidism-jaw tumour (HPT-JT) syndrome due to a hyperparathyroidism type 2 deletional-frameshift mutation (c.1239delA), respectively. Phenocopies may mimic MEN1 either by occurrence of a single sporadic endocrine tumour in a patient with familial MEN1, or occurrence of two endocrine abnormalities associated with different aetiologies. Phenocopies arose in >5% of MEN1 families, and awareness of them is important in the clinical management of MEN1 and other hereditary disorders. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:E1089 / E1101
页数:13
相关论文
共 50 条
  • [31] Multiple endocrine neoplasia type 1 with MEN1 variant of unknown significance, in a patient after the diagnosed of pancreatic neuroendocrine neoplasia
    Tanaka, Yuko
    Niitani, Takafumi
    Matsumoto, Takatsugu
    Abe, Akihito
    Ishida, Kazuyuki
    Aoki, Taku
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (03): : 263 - 267
  • [32] Novel Association of Thymic Carcinoid with a Germline Mutation in a Kindred with Multiple Endocrine Neoplasia 1 (MEN1)
    Khoo, J.
    Bee, Y. M.
    Giraud, S.
    Chen, R. Y. J.
    Rajasoorya, C.
    Teh, B. -T.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2012, 120 (05) : 257 - 260
  • [33] Multiple Endocrine Neoplasia Type 1 (MEN1) 5′UTRDeletion, inMEN1Family, Decreases Menin Expression
    Kooblall, Kreepa G.
    Boon, Hannah
    Cranston, Treena
    Stevenson, Mark
    Pagnamenta, Alistair T.
    Rogers, Angela
    Grozinsky-Glasberg, Simona
    Richardson, Tristan
    Flanagan, Daniel E. H.
    Taylor, Jenny C.
    Lines, Kate E.
    Thakker, Rajesh, V
    JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (01) : 100 - 109
  • [34] Role of 68Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)
    Secondo Lastoria
    Francesca Marciello
    Antongiulio Faggiano
    Luigi Aloj
    Corradina Caracò
    Michela Aurilio
    Laura D’Ambrosio
    Francesca Di Gennaro
    Valeria Ramundo
    Luigi Camera
    Leonardo De Luca
    Rosa Fonti
    Vincenzo Napolitano
    Annamaria Colao
    Endocrine, 2016, 52 : 488 - 494
  • [35] Features of Multiple Endocrine Neoplasia Type 1 and 2A in a Patient with Both RET and MEN1 Germline Mutations
    Brown, Spandana J.
    Riconda, Daniel L.
    Zheng, Feibi
    Jackson, Gilchrist L.
    Suo, Liye
    Robbins, Richard J.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (04)
  • [36] Role of 68Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)
    Lastoria, Secondo
    Marciello, Francesca
    Faggiano, Antongiulio
    Aloj, Luigi
    Caraco, Corradina
    Aurilio, Michela
    D'Ambrosio, Laura
    Di Gennaro, Francesca
    Ramundo, Valeria
    Camera, Luigi
    De Luca, Leonardo
    Fonti, Rosa
    Napolitano, Vincenzo
    Colao, Annamaria
    ENDOCRINE, 2016, 52 (03) : 488 - 494
  • [37] Multiple endocrine neoplasia type 1
    Doherty, GM
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 89 (03) : 143 - 150
  • [38] Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1)
    Giusti, Francesca
    Cianferotti, Luisella
    Gronchi, Giorgio
    Cioppi, Federica
    Masi, Laura
    Faggiano, Antongiulio
    Colao, Annamaria
    Ferolla, Piero
    Brandi, Maria Luisa
    ENDOCRINE, 2016, 52 (03) : 495 - 506
  • [39] Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: Two case reports of an unrecognised entity
    A. Agha
    R. Carpenter
    S. Bhattacharya
    S. J. Edmonson
    E. Carlsen
    J. P. Monson
    Journal of Endocrinological Investigation, 2007, 30 : 145 - 149
  • [40] A novel missense mutation of the MEN1 gene in a multiple endocrine neoplasia type 1 patient associated with carcinoid syndrome
    Ukita, C
    Yamaguchi, M
    Tanaka, T
    Shigeta, H
    Nishikawa, M
    INTERNAL MEDICINE, 2003, 42 (11) : 1112 - 1116